This case series investigates the association of a segmental, facial, antibody-associated brainstem sensory syndrome with the immune checkpoint inhibitor pembrolizumab.

Association Between a Distinctive Autoantibody-Associated Brainstem Sensory Syndrome and Immune Checkpoint Inhibitors / Damato, V; Berretta, A; Ramanathan, S; Michael, S; Coupe, N; Payne, M; Irani, SR. - In: JAMA NEUROLOGY. - ISSN 2168-6149. - ELETTRONICO. - 79:(2022), pp. 949-951. [10.1001/jamaneurol.2022.1824]

Association Between a Distinctive Autoantibody-Associated Brainstem Sensory Syndrome and Immune Checkpoint Inhibitors

Damato, V
Conceptualization
;
2022

Abstract

This case series investigates the association of a segmental, facial, antibody-associated brainstem sensory syndrome with the immune checkpoint inhibitor pembrolizumab.
79
949
951
Damato, V; Berretta, A; Ramanathan, S; Michael, S; Coupe, N; Payne, M; Irani, SR
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2158/1285529
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact